MARKET WRAP: JSE at record high but vaccine rollout a worry
The government is in advanced talks with Johnson & Johnson to secure an additional 20-million doses of its Covid-19 vaccine
09 February 2021 - 18:47
The JSE closed firmer on Tuesday amid mixed global markets as investors digest US stimulus prospects and global vaccine rollouts.
The JSE all share remained at a record high after closing above 65,000 points for the first time on Monday. Tuesday’s gains were relatively small, however, as investors remain cautious following SA’s vaccine setback...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.